Categories Analysis, Consumer

Key takeaways from Constellation Brands’ Q4 earnings report

For fiscal year 2024, the company expects reported EPS to range between $11.60-11.90

Shares of Constellation Brands, Inc. (NYSE: STZ) were up 1% on Thursday, after the company reported its earnings results for the fourth quarter of 2023. While the bottom line surpassed projections, the top line fell short. The company also hiked its quarterly dividend. Here’s a look at the key takeaways from the report:

Mixed results

Constellation’s net sales for the fourth quarter of 2023 fell 5% year-over-year to $1.99 billion, missing the consensus estimate of $2.02 billion. Net income attributable to CBI decreased 44% to $223 million, or $1.21 per share, compared to last year. Comparable EPS fell 16% to $1.98 but surpassed projections of $1.82. EPS, excluding Canopy, was $2.15, also down 16%.

Category performance

Constellation’s beer business saw sales drop by 2% to $1.53 billion in Q4 with shipments falling by 5.4%. Depletions grew 6.3%, driven by strong performances from Modelo Especial and Corona Extra. Operating margin in this segment decreased by 510 basis points due to higher packaging, raw material, and logistics costs as well as higher SG&A expenses.

Net sales in the wine and spirits division fell 14% YoY to $462.2 million, while organic sales were down 9%. Shipments were down 22% on a reported basis and 19% on an organic basis. Overall depletions were down nearly 5% but the company saw strong gains across some of its higher-end brands such as Kim Crawford, The Prisoner Wine Co. and Casa Noble.

Outlook

For fiscal year 2024, Constellation Brands expects reported EPS to range between $11.60-11.90 while comparable EPS, excluding Canopy, is estimated to be $11.70-12.00. Net sales for the beer business is expected to grow 7-9% for the year while operating income is expected to grow 5-7%. Organic net sales in the wine and spirits division is projected to be down 0.5% to up 0.5% in FY2024 while operating income growth, excluding certain items, is estimated to be 2-4%.

Dividend

Constellation’s board of directors declared a quarterly cash dividend of $0.89 per share of Class A Common Stock, reflecting an increase of 11%, payable on May 18, 2023 to stockholders of record as of May 4.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top